|
Mar 27
|
Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
|
|
Mar 26
|
Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts
|
|
Mar 26
|
AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication
|
|
Mar 26
|
UPDATE 1-China to speed up 'new productive forces', vice president says
|
|
Mar 25
|
Astrazeneca (AZN) Dips More Than Broader Market: What You Should Know
|
|
Mar 25
|
31 European Countries That Offer Citizenship by Descent
|
|
Mar 25
|
German industry sceptical of China's vow to treat foreign firms equally
|
|
Mar 25
|
Can Ionis' (IONS) Wholly-Owned Drugs Cut Dependency on Collabs?
|
|
Mar 25
|
ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
|
|
Jan 30
|
AstraZeneca's (AZN) sBLA for Enhertu Gets FDA's Priority Tag
|
|
Jan 29
|
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with metastatic HER2-positive solid tumors
|
|
Jan 29
|
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
|
|
Jan 27
|
3 Magnificent Stocks to Buy and Hold Forever
|
|
Jan 25
|
24 Least Developed Countries in Europe in 2024
|
|
Jan 25
|
PRESS DIGEST-British Business - Jan 25
|
|
Jan 16
|
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|
|
Jan 16
|
4 Pharma Stocks to Buy, According to an Analyst. Novo Nordisk Isn’t One.
|
|
Jan 16
|
Trending tickers: Apple | Tesla | AstraZeneca | Hugo Boss
|
|
Jan 15
|
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca
|
|
Jan 12
|
Astrazeneca (AZN) Laps the Stock Market: Here's Why
|